APA (7th ed.) Citation

Plomer, E., Früh, M., Lauber, A., Demmer, I., Jochum, W., & Koster, K. (2024). Prolonged Response to Afatinib and Crizotinib in a Rare Case of EGFR -, HER2 -, MET - and ROS1 -Alterated Lung Adenocarcinoma. International Journal of Molecular Sciences, 25(11), 5698. https://doi.org/10.3390/ijms25115698

Chicago Style (17th ed.) Citation

Plomer, Eva, Martin Früh, Arno Lauber, Izadora Demmer, Wolfram Jochum, and Kira-Lee Koster. "Prolonged Response to Afatinib and Crizotinib in a Rare Case of EGFR -, HER2 -, MET - and ROS1 -Alterated Lung Adenocarcinoma." International Journal of Molecular Sciences 25, no. 11 (2024): 5698. https://doi.org/10.3390/ijms25115698.

MLA (9th ed.) Citation

Plomer, Eva, et al. "Prolonged Response to Afatinib and Crizotinib in a Rare Case of EGFR -, HER2 -, MET - and ROS1 -Alterated Lung Adenocarcinoma." International Journal of Molecular Sciences, vol. 25, no. 11, 2024, p. 5698, https://doi.org/10.3390/ijms25115698.